Literature DB >> 14631498

Effect of NMDA on production of reactive oxygen species by human lymphocytes.

E O Tuneva1, O N Bychkova, A A Boldyrev.   

Abstract

Low concentrations (<20 microM) of N-methyl-D-aspartate (NMDA), an agonist of specific receptors of brain glutamatergic systems, promote the formation of reactive oxygen species (ROS) both in the whole blood and in lymphocyte fraction. Further increase in NMDA concentrations led to progressive increase in ROS content in the whole blood, but to its decrease in lymphocyte suspension. The activating effect of NMDA is abolished by antioxidant N-acetylcysteine (5 mM) and NMDA-type glutamate receptor antagonist MK-801 (5 microM). Phorbol myristate acetate (PMA, 1 microM) also increased ROS content in the examined structures. This effect was antagonized by N-acetylcysteine, but not MK-801.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14631498     DOI: 10.1023/a:1026366907084

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  6 in total

1.  NMDA receptors are expressed in lymphocytes activated both in vitro and in vivo.

Authors:  Anna P Mashkina; Dasha Cizkova; Ivo Vanicky; Alexander A Boldyrev
Journal:  Cell Mol Neurobiol       Date:  2010-04-23       Impact factor: 5.046

2.  VGluT2 and NMDAR1 expression in cells in the inflammatory infiltrates in experimentally induced myositis: evidence of local glutamate signaling suggests autocrine/paracrine effects in an overuse injury model.

Authors:  Christoph Spang; Alexander Scott; Patrik Danielson; Ronny Lorentzon; Sture Forsgren
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

Review 3.  The dichotomy of NMDA receptor signaling.

Authors:  Sofia Papadia; Giles E Hardingham
Journal:  Neuroscientist       Date:  2007-12       Impact factor: 7.519

4.  Transient forebrain ischemia impact on lymphocyte DNA damage, glutamic acid level, and SOD activity in blood.

Authors:  Petra Kravcukova; Viera Danielisova; Miroslava Nemethova; Jozef Burda; Miroslav Gottlieb
Journal:  Cell Mol Neurobiol       Date:  2009-03-04       Impact factor: 5.046

Review 5.  Cellular prion protein and NMDA receptor modulation: protecting against excitotoxicity.

Authors:  Stefanie A G Black; Peter K Stys; Gerald W Zamponi; Shigeki Tsutsui
Journal:  Front Cell Dev Biol       Date:  2014-08-28

6.  The effect of memantine, an antagonist of the NMDA glutamate receptor, in in vitro and in vivo infections by Trypanosoma cruzi.

Authors:  Higo Fernando Santos Souza; Sandra Carla Rocha; Flávia Silva Damasceno; Ludmila Nakamura Rapado; Elisabeth Mieko Furusho Pral; Claudio Romero Farias Marinho; Ariel Mariano Silber
Journal:  PLoS Negl Trop Dis       Date:  2019-09-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.